iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) — ETF Analysis on Winston

Key Facts

• Issuer: IShares
• Asset Class: Stock
• Price: $9.16
• Expense Ratio: 35.00%
• Assets Under Management: $931M
• Number of Holdings: 254
• Inception Date: 2017-10-18
• Currency: EUR

Winston Score

iShares Nasdaq US Biotechnology UCITS ETF has a Winston Score of 72 out of 100.

Performance

• 1-Year Return: 56.41%
• 3-Year Return: 67.89%
• 5-Year Return: 42.30%

Top Holdings

AMGEN INC (N/A%), VERTEX PHARMACEUTICALS (N/A%), GILEAD SCIENCES INC (N/A%), REGENERON PHARMACEUTICALS (N/A%), REVOLUTION MEDICINES (N/A%)

Sector Breakdown

Healthcare (N/A%)